Canine Astrovirus

Overview and Taxonomy of Canine Astrovirus

Taxonomic Classification and Nomenclature

Canine astrovirus (CaAstV) occupies a clearly defined position within the family Astroviridae, a group of nonenveloped, single-stranded positive-sense RNA viruses that infect a broad spectrum of mammalian and avian hosts [1, 17]. The family is partitioned into two genera: Avastrovirus, which encompasses viruses infecting avian species, and Mamastrovirus, which includes those infecting mammalian hosts [1, 17]. Within the genus Mamastrovirus, CaAstV is classified under the species Mamastrovirus canis (historically designated as Mamastrovirus 5, or MAstV5) [2, 18]. This taxonomic assignment is supported by phylogenetic analyses of conserved genomic regions, particularly the RNA-dependent RNA polymerase (RdRp) encoded within open reading frame 1b (ORF1b), which consistently clusters canine isolates within a monophyletic clade distinct from other mamastroviruses [9, 16]. The original proposal to establish CaAstV as a distinct species within Mamastrovirus was put forward by Toffan et al. (2009) following the first genetic characterization of the virus from symptomatic puppies, which demonstrated that the ORF2 capsid sequences clustered closest to, yet remained genetically distinct from, a group comprising human, porcine, and feline astroviruses [17]. Since that foundational work, the nomenclature has undergone refinement, with the International Committee on Taxonomy of Viruses (ICTV) currently recognizing Mamastrovirus canis as the official species designation [2, 18]. It is important to note that the terms “CaAstV,” “CAstV,” and “MAstV5” are used interchangeably in the contemporary literature, though the latter is preferred in formal taxonomic contexts [2, 13].

The broader family Astroviridae itself is characterized by a remarkable degree of genetic plasticity, driven by an error-prone RNA-dependent RNA polymerase and frequent recombination events [21]. This inherent variability has profound implications for CaAstV taxonomy, as the delineation of lineages and genotypes within the species Mamastrovirus canis remains an area of active investigation. Early classification schemes, based primarily on partial ORF1b sequences, suggested the existence of three to four major lineages [7, 9, 15]. However, as complete genome and full-length ORF2 sequence data have accumulated, a more nuanced picture has emerged. Zhang et al. (2020), in a landmark genomic study, identified four major lineages (designated Lineages 1–4) based on phylogenetic analysis of the ORF2 gene, with Lineage 4 itself potentially arising from a recombination event between Lineage 2 and Lineage 3 strains [7]. Subsequent work has refined this framework, with some studies identifying up to five distinct lineages circulating globally [1]. The recent characterization of a Thai strain (OR220030_G21/Thailand/2021) that forms a unique, deeply branched lineage in phylogenetic analyses, without evidence of recombination, suggests that additional basal lineages may yet be discovered, particularly in under-sampled geographic regions [4]. This genetic heterogeneity underscores the dynamic evolutionary trajectory of CaAstV and presents ongoing challenges for diagnostics, vaccine development, and epidemiological surveillance.

Genomic Architecture and Molecular Organization

The CaAstV genome is a linear, positive-sense, single-stranded RNA molecule of approximately 6.6 kilobases (kb) in length, a size consistent with other members of the Astroviridae family [1, 9]. The genomic organization is conserved, comprising three primary open reading frames (ORFs): ORF1a, ORF1b, and ORF2, arranged in a 5′ to 3′ orientation [1, 3, 9]. ORF1a and ORF1b, located at the 5′ end of the genome, encode the nonstructural proteins. ORF1a codes for a protease and other proteins involved in viral replication and host-cell modulation, while ORF1b encodes the RNA-dependent RNA polymerase (RdRp), the most conserved protein across all astroviruses [1, 3]. The junction between ORF1a and ORF1b contains a ribosomal frameshift signal that allows for the translation of the ORF1a-ORF1b fusion polyprotein, a mechanism essential for efficient replication [21]. The ORF1b gene is highly conserved among CaAstV strains and is frequently targeted for diagnostic assay design, including the recently developed duplex quantitative real-time PCR (dqPCR) and SYBR Green-based RT-qPCR assays [2, 3, 6]. The high degree of sequence conservation in ORF1b also makes it a reliable target for phylogenetic analyses aimed at establishing the broader taxonomic relationships of CaAstV within the Mamastrovirus genus [7, 9].

In contrast, ORF2, located at the 3′ end of the genome, encodes the capsid protein (CP), the primary structural component of the virion and the most variable region of the CaAstV genome [1, 3, 7]. This hypervariability is a hallmark of astrovirus biology and is driven by the combination of polymerase infidelity and recombination, resulting in significant antigenic diversity [21]. The capsid protein is synthesized as a precursor polyprotein (typically ~86–90 kDa) that undergoes extensive proteolytic processing both inside and outside the host cell to yield mature structural proteins [20, 23]. This maturation process is critical for virion assembly, infectivity, and cellular tropism [23]. Structurally, the mature capsid spike domain, which protrudes from the icosahedral shell, is responsible for host-cell receptor binding and is the primary target of neutralizing antibodies [22, 23]. The three-dimensional organization of the CaAstV capsid spike, as elucidated through AlphaFold predictions, reveals a conserved β-barrel core with variable loops and turns that define lineage-specific antigenic profiles [13]. Shannon entropy analyses of the spike domain have identified discrete hypervariable regions that are enriched for surface-exposed residues, suggesting these sites are under immune-driven selection pressure [13]. Indeed, three amino acid substitutions located within predicted B-cell epitopes have been identified in Chinese strains, potentially facilitating host immune escape [7]. Furthermore, selection pressure analyses on ORF2 sequences from Vietnamese and Thai strains indicate that the capsid protein is predominantly under negative (purifying) selection, but with specific codons, often on B-cell epitopes, subject to positive selection [10]. This dynamic interplay between conservation and diversification at the capsid level is central to the virus’s ability to persist in canine populations and to generate new lineages.

Genetic Diversity, Lineage Classification, and Evolutionary Dynamics

The genetic diversity of CaAstV is extensive and is a defining feature of the virus. Early molecular surveys, limited by the availability of sequence data, often reported only a few lineages. However, the advent of next-generation sequencing (NGS) and metagenomic approaches has dramatically expanded our understanding of CaAstV diversity [5, 8, 12, 14]. As noted, phylogenetic analyses based on the full-length ORF2 gene currently support the existence of at least four major lineages (Lineages 1–4), with some studies proposing a fifth [1, 7, 11]. The geographic distribution of these lineages is broad, with evidence of multiple lineages circulating simultaneously within a single country or region. For instance, studies in Ecuador detected the circulation of four of the five known lineages [1]; in South Korea, strains from Lineages 1, 2, and 4 were identified [13]; and in Thailand, Lineages 1, 3, and 4 were found [11]. In China, strains belonging to Lineages 2, 3, and 4 have been reported, with Lineage 4 being particularly prevalent and showing evidence of temporal shifts in the dominant epidemic strains [7]. This co-circulation of multiple lineages in sympatric host populations creates opportunities for co-infection and, consequently, for recombination.

Recombination is a major driver of CaAstV evolution and is now recognized as a frequent event within the ORF2 gene [7, 9]. The first definitive evidence of recombination in CaAstV was reported by Li et al. (2018) in strains from southwest China, where four out of five complete ORF2 sequences cloned from diarrheic dogs exhibited putative recombination events [9]. Zhang et al. (2020) subsequently identified a recombinant lineage (Lineage 4) that appears to have arisen from inter-clade recombination between Lineage 2 and Lineage 3 strains, demonstrating that recombination can generate entirely new, stable lineages [7]. More recently, a putative recombinant strain (JBN/22D16-1) was identified in South Korea, exhibiting a Group 2–like polymerase backbone (from ORF1b) and a Lineage 1 capsid gene (from ORF2), with a recombination breakpoint located near the ORF1b–ORF2 junction [13]. Similarly, three possible recombinant strains were identified in Ecuador, highlighting the global nature of this phenomenon [1]. The precise mechanisms and frequency of recombination in CaAstV remain areas of active research, but it is clear that this process, combined with point mutations, generates the high genetic diversity that challenges both immune recognition and diagnostic targeting [7, 21]. It is worth noting, however, that not all studies have detected recombination; for example, a comprehensive analysis of Vietnamese and Thai CaAstV strains found no evidence of recombination, suggesting that recombination may be episodic or dependent on the specific viral population structure [4, 10].

The evolutionary relationships of CaAstV also extend beyond the canine host. Phylogenetic analyses of the conserved ORF1b gene have revealed a close genetic relationship between CaAstV and California sea lion astroviruses, suggesting a potential historical cross-species transmission event or shared ancestry [7]. Furthermore, one study identified a CaAstV strain that was closely related to mink astrovirus, raising the possibility of interspecies transmission among mustelid and canid hosts [16]. These findings are consistent with the growing body of evidence that astroviruses are not strictly species-specific and can, under certain ecological or selective pressures, cross host-species barriers [21]. The detection of MAstV5 in a crab-eating fox (Cerdocyon thous) in Brazil further extends the known host range of CaAstV to wild canids, underscoring the potential for viral spillover between domestic and wildlife populations [19]. The identification of CaAstV in extraintestinal tissues, including spleen, liver, trachea, and mesenteric lymph nodes, in naturally infected dogs also challenges the traditional view of astroviruses as solely enteric pathogens and suggests a capacity for systemic dissemination [2, 10]. This phenomenon has been documented for other astroviruses, including human astrovirus VA1 (associated with neurological disease) and porcine astrovirus 3 (associated with polioencephalomyelitis), indicating that extraintestinal tropism may be a more common feature of the Astroviridae than previously appreciated [20, 24]. These observations collectively paint a picture of CaAstV as a genetically dynamic, broadly distributed, and ecologically adaptable virus, with implications for both canine health and the broader field of astrovirus evolution.

Molecular Pathogenesis of Canine Astrovirus

Viral Entry and Cellular Tropism

The molecular pathogenesis of canine astrovirus (CaAstV) begins with the intricate process of host cell attachment and entry, a sequence governed entirely by the structural architecture of the capsid protein. As a non-enveloped, icosahedral virus, CaAstV relies on the capsid spike domain, encoded by the hypervariable open reading frame 2 (ORF2), for initial receptor engagement on susceptible enterocytes [1, 23]. Structural modeling of the CaAstV capsid, using advanced computational techniques such as AlphaFold, has revealed a conserved three-domain organization comprising a core domain, a spike domain, and a C-terminal domain, with the spike domain containing a conserved β-barrel core and a distinct β-strand topology that governs host cell adhesion [13]. The spike domain of astroviruses is the primary determinant of receptor binding, and for classical human astroviruses, evidence indicates that neutralizing antibodies block infection by preventing this attachment step [22]. While the specific cellular receptor for CaAstV on canine intestinal epithelium remains uncharacterized, comparative structural studies of diverse astroviruses, including the divergent human MLB-clade, suggest that different clades may utilize distinct receptors for attachment, a hypothesis supported by the lack of a conserved receptor-binding site between classical and MLB astrovirus spikes [30]. This structural divergence implies that CaAstV likely engages a unique, species-specific receptor on canine cells, the identity of which remains a critical gap in our understanding of its pathogenesis.

Once bound, the virus is internalized, likely via clathrin-mediated endocytosis, a process common to many enteric non-enveloped viruses. Following internalization, the capsid undergoes a coordinated, proteolytic maturation process that is essential for infectivity. In human astroviruses, the full-length capsid precursor protein (VP86 in VA1 strains) is proteolytically cleaved intracellularly into mature structural proteins, including VP33 (the core domain) and VP38 (the spike domain), a processing step that is indispensable for the production of infectious progeny [20]. For CaAstV, the capsid protein is known to undergo dramatic proteolytic processing both inside and outside the host cell, ultimately controlling genome release into the cytoplasm [23]. This maturation is critical for exposing the viral genome for translation and replication.

A seminal discovery in astrovirus pathogenesis was the identification of the primary target cell for productive infection in the gut. Using a murine astrovirus model, Cortez et al. (2020) demonstrated that astrovirus preferentially infects actively secreting goblet cells within the small intestine [31]. This cell tropism is a cornerstone of CaAstV molecular pathogenesis, as goblet cells are specialized epithelial cells responsible for the production and secretion of mucins, the primary structural components of the protective mucus barrier. The infection of goblet cells is not a passive event; it directly alters the host's mucosal defense system. Astrovirus infection leads to a significant alteration in mucus production, resulting in a disruption of the tightly regulated mucus barrier [31]. This disruption has profound consequences: it leads to an increase in mucus-associated bacterial communities, altering the gut microbiome composition and potentially facilitating secondary bacterial infections. Furthermore, this alteration in the mucus barrier can paradoxically create resistance to other enteric pathogens, such as enteropathogenic E. coli, demonstrating a complex and nuanced role for astrovirus in shaping the intestinal ecosystem [31]. For CaAstV, it is highly plausible that a similar goblet cell tropism exists, given the conserved nature of astrovirus biology and the similar clinical presentation of enteric disease in dogs.

Genome Organization and Replicative Machinery

Canine astrovirus possesses a linear, positive-sense, single-stranded RNA genome of approximately 6.6 kb, which is organized into three canonical open reading frames: ORF1a, ORF1b, and ORF2 [1, 9]. ORF1a and ORF1b encode the non-structural proteins, including the viral protease and the RNA-dependent RNA polymerase (RdRp), which are the most conserved regions of the genome [1, 7]. The RdRp is a critical determinant of viral replication fidelity, and its inherently error-prone nature is a primary driver of the high genetic variability observed among CaAstV strains [21]. The low fidelity of the RdRp introduces mutations at a high rate, leading to the emergence of quasispecies within a single host, which can facilitate rapid adaptation to selective pressures such as host immune responses. ORF1a encodes a serine protease responsible for cleaving the viral polyprotein into functional non-structural components, a process essential for establishing the replication complex. The junction between ORF1b and ORF2 is a known hotspot for recombination, a phenomenon that has profound implications for CaAstV evolution and pathogenesis. Recombination events at this boundary can shuffle capsid genes (ORF2) onto different polymerase backbones (ORF1b), creating novel chimeric viruses with potentially altered tropism, antigenicity, or pathogenicity [7, 9].

Capsid-Driven Genetic Diversity and Immune Evasion

The ORF2 gene, which encodes the capsid protein, is the most variable region of the CaAstV genome, accounting for the extensive antigenic and genetic diversity within the species Mamastrovirus canis [1, 7]. Phylogenetic analyses of ORF2 have consistently delineated CaAstV strains into multiple distinct lineages, currently numbering at least four major lineages, with evidence for a fifth [7, 11, 13]. This genetic heterogeneity is not merely a taxonomic curiosity; it has direct functional consequences. The capsid protein is the primary target of the host humoral immune response, and neutralizing antibodies are directed against the surface-exposed spike domain. Amino acid substitutions within predicted B-cell epitopes of the capsid are a key mechanism for immune evasion. Zhang et al. (2020) identified three specific amino acid substitutions located in predicted B-cell epitopes that may be involved in the escape of host immunity, allowing newly emergent strains to reinfect previously exposed or vaccinated dogs [7]. Shannon entropy analyses of the capsid spike domain reveal that high-variability sites are clustered in discrete, surface-exposed regions within a broadly conserved structural scaffold, and these variable regions are precisely where predicted linear B-cell epitopes are mapped [13]. This pattern of concentrated diversity in antigenic hotspots is characteristic of a virus under strong selective pressure from the host immune system.

Recombination is arguably the most potent evolutionary force shaping CaAstV capsid diversity. Unlike point mutations, which introduce incremental changes, recombination can generate entirely new capsid lineages by swapping large genomic segments. Frequent inter-clade ORF2 gene recombinants have been identified, and a distinct recombinant lineage (lineage 4) is thought to have evolved from a recombination event between lineage 2 and lineage 3 strains [7]. Li et al. (2018) provided the first report of recombination events in CaAstV, discovering putative recombination events in the ORF1a, ORF1b, and ORF2 genes, with one strain exhibiting a continuous 7-amino-acid insertion in region II of ORF2, suggesting a novel genotype [9]. These recombination events can drastically alter the antigenic profile of the virus, potentially leading to immune escape in populations with pre-existing immunity. The identification of putative recombinant strains, such as the JBN/22D16-1 strain from South Korea which possesses a group 2-like polymerase backbone and a lineage one capsid gene, underscores the dynamic and ongoing nature of this evolutionary process [13].

Mechanisms of Cellular Injury and Systemic Dissemination

While traditionally considered an exclusively enteric pathogen, mounting evidence indicates that CaAstV can disseminate beyond the gastrointestinal tract, establishing a systemic infection. This paradigm shift in our understanding of CaAstV pathogenesis is supported by the detection of viral RNA in extraintestinal tissues, including the spleen, liver, trachea, and mesenteric lymph nodes of naturally infected dogs [2]. This systemic distribution suggests that the virus is capable of breaching the intestinal epithelial barrier, possibly through infected goblet cells or via M cells overlying Peyer’s patches, and entering the lymphatic or circulatory systems. The presence of CaAstV RNA in the mesenteric lymph nodes is particularly significant, as it indicates active viral trafficking through the lymphatic system, a route commonly used by enteric viruses to gain access to the systemic circulation. Furthermore, the detection of viral RNA in the liver and spleen implies a broader tissue tropism than previously appreciated. The clinical significance of this systemic dissemination is not fully understood, but it may contribute to the lethargy and depression frequently observed in infected dogs, potentially through the induction of systemic inflammatory responses.

At the cellular level, the primary pathological insult occurs within the intestinal epithelium. The infection and lysis of goblet cells directly compromise the integrity of the mucus barrier [31]. This barrier disruption increases intestinal permeability, a condition often referred to as "leaky gut," which allows luminal contents, including bacterial products and antigens, to translocate across the epithelium and trigger inflammation. The resulting inflammatory cascade contributes to the clinical signs of diarrhea and abdominal discomfort. The viral loads are typically highest in younger animals, particularly puppies under six months of age, correlating with the highest prevalence and severity of clinical disease [3, 4, 10]. This age-related susceptibility is likely multifactorial, stemming from an immature immune system, an underdeveloped gut microbiome, and the still-developing intestinal epithelial barrier.

Immune Modulation and Host Response

The host immune response to CaAstV is a delicate balance between viral clearance and immunopathology. The capsid protein directly interacts with the host complement system. Astrovirus capsids have been shown to bind host complement proteins and inhibit complement activation, representing an immune evasion strategy that dampens the host's innate antiviral defenses [23]. This inhibition of the complement cascade reduces opsonization, neutralization, and the recruitment of inflammatory cells, providing the virus with a window of opportunity to establish infection.

In terms of adaptive immunity, the humoral response is crucial. Antibodies against the capsid spike domain are neutralizing and can block virus attachment to host cells [22]. However, the high genetic diversity of the ORF2 gene, particularly in the spike domain, allows for the emergence of antigenic variants that can evade pre-existing neutralizing antibodies. This is particularly concerning in the context of vaccination, as a vaccine based on a single lineage may not provide broad protection against all circulating lineages. Analyses of selective pressure on the capsid gene have predominantly indicated negative (purifying) selection, suggesting that most amino acid changes are deleterious and are removed from the population [10]. However, the presence of positive selection sites within B-cell epitopes indicates that specific, targeted changes that enhance immune evasion are favored [10]. The detection of CaAstV in both symptomatic and asymptomatic dogs across numerous studies highlights the complexity of this host-pathogen interaction, where the outcome of infection, ranging from subclinical shedding to severe hemorrhagic gastroenteritis, is determined by a convergence of viral factors (strain virulence, lineage, co-infection status) and host factors (age, immune competence, genetic background, microbiome composition) [4, 25, 26].

The Exacerbating Role of Co-Infections

A hallmark of CaAstV molecular pathogenesis is its frequent involvement in polymicrobial enteric infections. Co-infections are the rule, rather than the exception, with CaAstV commonly detected alongside other major canine enteric pathogens, including canine parvovirus type 2 (CPV-2), canine coronavirus (CCoV), canine distemper virus (CDV), and canine kobuvirus (CaKoV) [1, 3, 5, 9, 10, 28, 29]. The synergistic interactions between these viruses can profoundly exacerbate clinical disease. The classic example is the outbreak of severe hemorrhagic gastroenteritis (HGE) with high mortality in vaccinated Jack Russell Terrier puppies in Hungary, where co-infection with a novel CPV-2b variant and CaAstV was identified as the etiological agent [5]. In this severe outbreak, the combined action of the two viruses likely overwhelmed the host's intestinal defenses, leading to profound tissue destruction, hemorrhage, and death. The high prevalence of co-infections, with some studies reporting CaAstV in over 70% of CPV-2-positive samples, suggests that CaAstV may act as an important predisposing factor or synergistic agent that amplifies the severity of disease caused by other pathogens [27].

Mechanistically, the disruption of the intestinal epithelium and mucus barrier by CaAstV could facilitate the invasion and dissemination of other enteric viruses like CPV-2, which targets rapidly dividing crypt epithelial cells. The inflammation and immune dysregulation induced by one virus may also create a more permissive environment for the replication of another. The prevalence of co-infections is particularly high in puppies and in dogs with poor health status, as environmental and management factors contribute to a higher pathogen burden [3, 5, 25]. The frequent detection of CaAstV in healthy dogs [4, 26] suggests that in many cases, the virus is avirulent or causes only mild, self-limiting disease. However, when the host is immunologically compromised or co-infected with a highly pathogenic agent like CPV-2 or CDV, the molecular machinery of CaAstV can tip the balance toward severe, life-threatening illness. This complex interplay of viral and host factors underscores the importance of comprehensive diagnostic approaches that screen for multiple enteric pathogens simultaneously to fully understand and manage canine gastroenteritis.

Epidemiology and Global Distribution of Canine Astrovirus

Canine astrovirus (CaAstV), classified taxonomically as Mamastrovirus canis (MAstV 5) within the family Astroviridae and genus Mamastrovirus, has emerged as a globally distributed enteric pathogen of domestic dogs [1, 2]. Since the first definitive molecular characterization of CaAstV in the mid-2000s, which confirmed ultrastructural observations from the preceding decades [17, 40], a rapidly expanding body of epidemiological surveillance data has revealed that CaAstV circulates extensively across multiple continents, exhibiting substantial genetic diversity and complex epidemiological patterns [7, 32]. The global distribution of CaAstV is now documented across Europe, Asia, the Americas, and Oceania, with prevalence rates varying markedly by geographic region, diagnostic methodology, sampled population demographics, and the health status of the animals under investigation [4, 7, 9, 15]. This section provides an exhaustive synthesis of the current knowledge regarding the epidemiology and global distribution of CaAstV, drawing upon the most recent molecular epidemiological investigations, metagenomic surveys, and phylogenetic analyses.

Global Prevalence and Continental Distribution

The prevalence of CaAstV in canine populations demonstrates remarkable geographic variability. In Europe, early investigations in the United Kingdom identified CaAstV in four dogs presenting with gastroenteritis, with subsequent sequencing revealing the first complete CaAstV genome and underscoring significant capsid gene heterogeneity [32]. A comprehensive study in Hungary utilized viral metagenomics and next-generation sequencing (VM-NGS) to identify a CaAstV strain (FR1/CaAstV-2021-HUN) in an outbreak of severe haemorrhagic gastroenteritis among vaccinated Jack Russell Terrier puppies; this strain demonstrated close phylogenetic relatedness to a previously identified Hungarian strain, indicating sustained local circulation [5]. In Italy, a study on the Mediterranean island of Sardinia detected CaAstV in 20.5% of dogs displaying severe enteric clinical signs, highlighting the virus's significant presence in southern European canine populations [37]. Investigations in Greece have been particularly illuminating. Using SYBR-Green real-time RT-PCR, Stamelou et al. detected CaAstV in 15% of 201 domestic dogs, with the virus identified in both healthy and gastroenteritis-affected animals [26]. A subsequent, more targeted analysis employing multiple correspondence analysis (MCA) and ascending hierarchical classification (AHC) revealed that CaAstV occurrence was associated with low-health-status dogs, typically mongrels residing in rural areas, that exhibited clinical signs such as vomiting and diarrhoea and had frequent contact with other pets and stray animals [25]. This nuanced epidemiological profiling represents a significant advancement in understanding the socio-ecological determinants of CaAstV transmission.

In Asia, a substantial body of evidence documents widespread CaAstV circulation. A landmark investigation in southwest China reported a startling 39.3% positivity rate (42/107) among diarrhoeic dogs, with co-infection rates exceeding 97% [9]. This study also provided the first evidence of recombination events in CaAstV, a finding that has profoundly influenced subsequent evolutionary analyses [7, 9]. Earlier work in Guangxi, China, detected CaAstV in 25.3% of dogs with diarrhoea and 5.9% of clinically healthy dogs, demonstrating that asymptomatic carriage is a significant epidemiological feature [15]. The same study noted that a subset of sequences displayed higher similarity to porcine astrovirus (PoAstV) 5 and 2, raising the possibility of inter-species transmission or shared ancestral lineages [15]. A virome study of 1,970 canine fecal samples from the high-altitude plateau regions of Yushu and Guoluo in China identified CaAstV among 203 novel viruses, further confirming the virus's ubiquity in even remote canine populations [14]. In a controlled diagnostic setting, Wang et al. developed a one-step multiplex TaqMan probe-based real-time PCR and found CaAstV prevalence to be significantly higher than previously reported by conventional RT-PCR in Zhejiang, China, emphasizing that methodological sensitivity is a critical determinant of apparent prevalence [38]. In South Korea, a recent study detected CaAstV in 16.5% (13/79) of intestinal or fecal samples submitted for diagnostic testing between 2022 and 2023, with phylogenetic analyses revealing the circulation of lineages 1, 2, and 4 [13]. Earlier work in South Korea had reported a lower prevalence of 2.1% (2/91), suggesting either temporal fluctuations in prevalence or differences in the sampled population [39]. In Japan, CaAstV was detected in 3 of 31 diarrhoeic pups but not in any of 42 asymptomatic dogs [33]. The situation in Southeast Asia has been clarified by recent work in Vietnam and Thailand. Nguyen et al. reported an overall CaAstV prevalence of 25.7% (29/113) in Vietnam and 8.9% (19/214) in Thailand, with the virus detected in both diarrhoeic and non-diarrhoeic dogs, but with a statistically significant predilection for puppies under six months of age [4, 10]. A larger surveillance study in Thailand, encompassing 862 rectal swabs from domestic dogs collected between January 2022 and December 2023, found a CaAstV-positive rate of 4.2% (36/862), with complete genome sequencing identifying strains belonging to lineages 1, 3, and 4 [11].

In the Americas, the epidemiological picture has been dramatically shaped by recent investigations from Latin America. A landmark study in Ecuador tested 502 samples from dogs with gastrointestinal disease using a specific RT-qPCR with hydrolysis probes and detected CaAstV in an extraordinary 336 samples (66.9%), making it one of the highest prevalence rates ever reported globally [1]. Co-infection with canine parvovirus type 2 (CPV-2) was observed in 49.4% of positive samples, and 4% of samples were simultaneously infected with CaAstV, CPV-2, and canine coronavirus (CCoV) [1]. An earlier, methodologically distinct Ecuadorian study using SYBR Green-based RT-qPCR on 221 samples found a positivity rate of 53.8% (119/221) [3]. The consistency of these two independent studies within the same country suggests that CaAstV is hyperendemic in Ecuadorian dog populations. In Brazil, Alves et al. detected MAstV5 in 26% (71/269) of fecal samples, with all positive samples originating from dogs displaying clinical signs of gastroenteritis and frequently exhibiting co-infections with other enteropathogens [18]. Nearly complete genome sequences of two Brazilian strains (CAstV-PK01 and CAstV-PK03) from puppies with diarrhoea in the Amazon region have been reported, expanding the genomic data available from South America [35]. In North America, data remain comparatively sparse, though studies in the United States have confirmed CaAstV circulation. In Minnesota, two complete CaAstV sequences were obtained from deceased dogs with gastroenteritis using Illumina MiSeq sequencing, and subsequent screening of ten samples confirmed CaAstV in six [41]. A study in India detected CaAstV in 3.75% of 80 canine fecal samples from Western Maharashtra, while a larger survey from Gujarat reported a prevalence of 5.95% (10/168), with a higher rate of 9.86% among diarrhoeic dogs compared to 3.09% in healthy controls [29, 34]. In Australia, near-complete CaAstV genome sequences obtained via NGS from a kennel outbreak in Victoria demonstrated 94.7% identity with a UK strain from 2012, suggesting transcontinental viral movement [8].

Age-Specific Prevalence and Clinical Associations

A consistent finding across virtually all epidemiological studies is the age-dependent distribution of CaAstV infection. Young animals, particularly puppies under six months of age, are disproportionately affected [1, 3, 4, 10, 33, 42]. In Ecuador, the highest viral loads and prevalence rates were observed in the youngest canine age groups, specifically puppies up to 48 weeks of age [3]. Similarly, in the Vietnam and Thailand study, CaAstV was most frequently detected in puppies under six months of age (23.3%, p = 0.02), a statistically significant finding that underscores the heightened susceptibility of juvenile animals [4]. This age-related pattern is biologically plausible and mirrors the epidemiology of other enteric viruses; it likely reflects the waning of maternal antibody protection coupled with an immature adaptive immune system, making young dogs highly permissive to infection. The tropical and subtropical environments of many study sites may also facilitate year-round transmission, eliminating seasonal troughs that might reduce exposure in older animals.

The clinical significance of CaAstV infection remains a subject of active investigation. Many studies have detected the virus in both diarrhoeic and apparently healthy dogs, complicating the establishment of a clear causal link between CaAstV and clinical gastroenteritis. In Greece, Stamelou et al. reported a higher prevalence of CaAstV in healthy dogs (15%) compared to symptomatic dogs using SYBR-Green real-time RT-PCR, though this finding was influenced by the differential sensitivity of the diagnostic methods employed [26]. The 2025 study using MCA and AHC techniques in the same population revealed that CaAstV was more prevalent in low-health-status dogs showing clinical signs such as vomit and diarrhoea, suggesting that while the virus can be carried asymptomatically, it is often a contributing factor to gastrointestinal disease, particularly in immunologically or nutritionally compromised animals [25]. In China, Zhang et al. found CaAstV in 13.2% of pet dogs with diarrhoea but only 3.35% of those without, a significantly higher rate in symptomatic animals that supports a pathogenic role [7]. Studies from Japan detected CaAstV exclusively in diarrhoeic pups and not in any asymptomatic adults [33].

The emerging paradigm posits that CaAstV is a primary or contributing cause of gastroenteritis in a subset of cases, but its pathogenic potential is likely modulated by host factors (age, immune status, nutritional condition, concurrent infections) and viral factors (lineage, viral load, genetic determinants of virulence). The high frequency of co-infection with other enteric viruses, particularly CPV-2, CCoV, and canine kobuvirus (CaKoV), further complicates the attribution of clinical signs to CaAstV alone [1, 4, 5, 7, 9, 26-29, 35-37, 43]. The question of whether CaAstV acts as a primary pathogen, an opportunistic co-pathogen, or a precipitating agent that exacerbates the severity of other infections remains a central challenge in the field.

Co-Infection Dynamics and Ecological Interactions

Perhaps the most striking epidemiological feature of CaAstV is its extraordinary propensity for co-infection with other canine enteric pathogens. The literature is replete with reports documenting that CaAstV-positive samples are overwhelmingly also positive for other viruses. In Ecuador, co-infection with CPV-2 was found in 49.4% of CaAstV-positive dogs, while triple infections with CPV-2 and CCoV were observed in 4% of samples [1]. In southwest China, 41 of 42 CaAstV-positive diarrhoeic samples (97.6%) exhibited co-infection with at least one other virus, including CCoV, CPV-2, and canine distemper virus (CDV) [9]. A separate study from China investigating Torque teno canis virus (TTCaV) reported the first co-detection of CaAstV with this anellovirus [7]. Among stray dogs in Shanghai, the co-infection rate of CaAstV with CaKoV reached 73.33% [27]. In Ecuador, 61.3% of CaKoV-positive samples were also co-infected with CaAstV, CPV-2, or CCoV, with triple co-infections (CPV-2, CaAstV, CaKoV) being the most frequent combination [43].

This pervasive co-infection raises critical questions about viral ecology and pathogenesis. Are these co-infections simply a reflection of the high background prevalence of multiple enteric viruses in canine populations, or is there biological synergy? Evidence from a Hungarian outbreak of severe haemorrhagic gastroenteritis in vaccinated Jack Russell Terrier puppies points toward the latter possibility. The co-infection of an "Asian-origin" CPV-2c-to-2b point mutant with CaAstV was associated with high mortality, and the authors explicitly questioned whether CaAstV co-infection contributed to the severity of disease in animals that should have been protected by vaccination against CPV-2 [5]. This observation suggests that CaAstV may act as a virulence modifier, potentially disrupting epithelial barriers, altering mucosal immune responses, or providing trans-complementation factors that enhance the replication or pathogenicity of co-infecting agents. Experimental studies are urgently needed to test these hypotheses. In India, a three-year comprehensive molecular survey (2018-2021) found that 70.3% of animals vaccinated with a DHPPiL (distemper, hepatitis, parvovirus, parainfluenza, leptospirosis) vaccine were still positive for at least one virus, highlighting the limitations of current vaccination strategies and the potential role of CaAstV in vaccine failure scenarios [28].

Genetic Diversity and Global Lineage Distribution

The genetic diversity of CaAstV is a cornerstone of its epidemiology and a major driver of its global distribution patterns. Phylogenetic analyses, primarily based on the highly variable capsid ((ORF2)) gene, have consistently classified CaAstV strains into multiple distinct lineages. Early work by Caddy and Goodfellow identified four major lineages based on UK and Italian strains [32]. Subsequent studies have largely confirmed this classification while expanding it to include up to five recognized lineages [1, 7, 13]. The global distribution of these lineages is not uniform. Lineage 1 appears to be geographically widespread, with representatives identified in Europe, Asia, and the Americas [11, 13, 32]. Lineage 2 has been detected in Italy, France, South Korea, and Ecuador [1, 39]. Lineage 3 has been found in China, Thailand, and other Asian countries [7, 11]. Lineage 4, which has been hypothesized to have evolved from a recombinant ancestor of lineages 2 and 3, has a particularly broad distribution, having been identified in China, South Korea, Thailand, and Ecuador [1, 7, 13].

The role of recombination in driving CaAstV genetic diversity cannot be overstated. Frequent inter-clade recombination events within the ORF2 gene have been identified, and a specific recombinant lineage (lineage 4) has been proposed [7]. In China, Li et al. reported that four of five complete ORF2 sequences from diarrhoeic dogs showed evidence of putative recombination events, with three sequences forming a unique genetic group suggestive of a novel genotype [9]. In South Korea, a putative recombinant strain designated JBN/22D16-1 was identified through phylogenetic discordance between the ORF1b and ORF2 genes; recombination analysis revealed it possessed a group 2-like polymerase backbone and a lineage 1 capsid gene, with a breakpoint near the ORF1b–ORF2 junction [13]. These findings indicate that recombination is a potent evolutionary force shaping CaAstV populations and may facilitate the emergence of strains with altered antigenic or pathogenic properties. The identification of a unique lineage in Thailand (OR220030_G21/Thailand/2021) for which no recombination event could be detected suggests that lineage diversification also occurs through other, as-yet-uncharacterized evolutionary mechanisms [4, 10].

Within lineages, further complexity is introduced by amino acid substitutions in B-cell epitopes. Zhang et al. identified three amino acid substitutions located in predicted B-cell epitopes of the ORF2 capsid protein that may be involved in escape from host immunity, suggesting that antigenic drift is a continuing process within circulating lineages [7]. Similarly, Jeong et al. demonstrated through Shannon entropy analysis of the spike domain that high-variability sites are clustered in discrete regions within a broadly conserved scaffold, and that predicted linear B-cell epitopes mapped primarily to these variable, surface-exposed segments, exhibiting lineage-associated patterns [13]. The recurrent GQKSNSQY-containing central epitope in lineage 4 and a conserved C-terminal epitope in lineage 1 point toward lineage-specific antigenic signatures that may influence host susceptibility patterns and vaccine design strategies.

Transmission Dynamics and Host Range

The primary mode of CaAstV transmission is the fecal–oral route, typical for enteric astroviruses. Infected dogs shed large quantities of viral particles in their feces, facilitating direct transmission among littermates, kennel mates, and dogs in crowded environments such as shelters, breeding facilities, and veterinary clinics [8, 42]. The detection of CaAstV in asymptomatic animals is particularly significant for transmission dynamics, as subclinical shedders can serve as a silent reservoir that perpetuates infection within populations. The role of environmental contamination in transmission is plausible given the non-enveloped nature of astroviruses, which confers substantial resistance to desiccation and common disinfectants, allowing prolonged persistence in contaminated bedding, food bowls, and surfaces.

Evidence is accumulating that CaAstV may not be strictly confined to the gastrointestinal tract. A recent study using a validated duplex quantitative real-time PCR assay detected CaAstV RNA in extraintestinal tissues, including spleen, liver, trachea, and mesenteric lymph nodes, from naturally infected dogs, suggesting the potential for systemic dissemination [2]. This finding, if corroborated, has profound implications for our understanding of CaAstV pathogenesis and epidemiology, as it raises the possibility of alternative transmission routes (e.g., respiratory, hematogenous) and the potential for multi-organ pathology.

The host range of CaAstV, while primarily restricted to canids, may extend beyond domestic dogs. A notable study reported the detection of MAstV5 in a crab-eating fox (Cerdocyon thous), a wild canid, with the strain likely derived from a canine host, suggesting possible natural spillover events among wild Canidae species [19]. The close phylogenetic relationship between CaAstV and California sea lion astroviruses, based on ORF1b analysis, has been noted by Zhang et al., who speculated about historical inter-species transmission events [7]. Bovine astrovirus (BoAstV) has also been reported to have potential for cross-species transmission [44]. While direct evidence for CaAstV infecting humans remains absent, the genetic similarity between some animal and human astroviruses, coupled with the high mutation and recombination rates of these viruses, keeps the possibility of zoonotic spillover on the scientific radar, particularly for immunocompromised individuals [21, 45]. The World Health Organization (WHO) recognizes astroviruses as significant causes of human gastroenteritis, particularly in children, and the Food

Clinical Manifestations and Disease Association

The Spectrum of Gastrointestinal Disease: From Subclinical Shedding to Severe Enteritis

The clinical manifestations of canine astrovirus (CaAstV) infection are remarkably heterogeneous, ranging from completely subclinical infections to severe, life-threatening gastroenteritis. This variability has been a central challenge in definitively establishing CaAstV as a primary enteric pathogen, as the virus is frequently detected in both diarrheic and apparently healthy dogs across diverse geographical settings [4, 7, 15, 26]. The most commonly reported clinical signs in symptomatic animals include acute-onset diarrhea, vomiting, lethargy, anorexia, and dehydration, with the severity often correlating with age, immune status, and the presence of concurrent infections [1, 3, 42]. The diarrhea is typically watery and non-hemorrhagic, though severe cases, particularly those involving co-infections, can progress to hemorrhagic gastroenteritis (HGE) with high mortality rates [5]. In a landmark outbreak investigation in Hungary, Boros et al. (2022) documented a colony of vaccinated purebred Jack Russell Terriers where a co-infection of CaAstV with a novel “Asian-origin” CPV-2b point mutant resulted in severe HGE and high mortality, underscoring the potential for astrovirus to exacerbate disease severity in the context of other viral pathogens [5]. This synergy is further supported by large-scale epidemiological studies from Ecuador, where Loor-Giler et al. (2025) found that 49.4% of CaAstV-positive dogs were co-infected with canine parvovirus type 2 (CPV-2), and an additional 4% harbored triple infections with CPV-2 and canine coronavirus (CCoV) [1]. The clinical picture in these co-infected animals was consistently more severe, with profound dehydration, protracted vomiting, and a higher likelihood of fatal outcomes compared to dogs infected with CaAstV alone [1, 3]. The pathophysiological basis for this synergy likely involves virus-induced disruption of the intestinal epithelial barrier, which facilitates the systemic spread and enhanced replication of co-infecting agents, a mechanism well-documented for other astroviruses in mammalian hosts [31].

The Enigma of Asymptomatic Infection and Subclinical Shedding

A substantial body of evidence now indicates that CaAstV can be detected in a significant proportion of dogs without any clinical signs of gastrointestinal disease, complicating the interpretation of its pathogenic role. In a comprehensive study across Vietnam and Thailand, Nguyen et al. (2023) reported CaAstV prevalence rates of 21.7% and 7.5% in non-diarrheic dogs, respectively, compared to 28.4% and 10.3% in dogs with diarrhea [4]. Similarly, Zhou et al. (2017) in Guangxi, China, found that 5.9% of apparently healthy pet dogs shed astrovirus in their feces [15]. Stamelou et al. (2022) in Greece even observed a higher prevalence of CaAstV in healthy dogs (15%) compared to symptomatic animals using SYBR-Green real-time RT-PCR, though this discrepancy may reflect differences in assay sensitivity and the transient nature of viral shedding [26]. These findings suggest that CaAstV can establish persistent or intermittent infections in the canine gut without eliciting overt disease, a phenomenon well-recognized for other mamastroviruses, including bovine astrovirus, which is frequently detected in healthy cattle [44]. The biological mechanisms underlying this subclinical carrier state are not fully elucidated but may involve host immune tolerance, viral genetic factors that attenuate pathogenicity, or the presence of a protective gut microbiome. Importantly, asymptomatic shedders represent a significant reservoir for environmental contamination and onward transmission, particularly in kennels, shelters, and multi-dog households [25]. Stamelou et al. (2025) employed advanced statistical modeling (Multiple Correspondence Analysis and Ascending Hierarchical Classification) to demonstrate that CaAstV-positive dogs in Greece were more likely to be low-health-status mongrels living in rural areas with frequent contact with stray animals, suggesting that environmental and management factors, rather than viral virulence alone, dictate clinical outcome [25].

Age-Related Susceptibility and the Role of Co-Infections

Age is arguably the most critical host factor influencing the clinical expression of CaAstV infection. Puppies, particularly those under six months of age, are disproportionately affected, exhibiting higher viral loads, more severe clinical signs, and a greater likelihood of co-infection with other enteric pathogens [3, 4, 42]. Loor-Giler et al. (2024) in Ecuador demonstrated that the highest CaAstV prevalence and viral loads were concentrated in dogs up to 48 weeks of age, with puppies as young as two weeks old showing the most severe dehydration and mortality [3]. This age-dependent susceptibility is likely multifactorial, reflecting the immaturity of the neonatal immune system, the absence of maternally derived antibodies, and the vulnerability of the developing gut epithelium. The clinical presentation in young puppies can be indistinguishable from that of canine parvovirus enteritis, with profuse watery or mucoid diarrhea, vomiting, depression, and rapid progression to hypovolemic shock if left untreated [42]. Co-infections are the rule rather than the exception in symptomatic CaAstV cases, with CPV-2 being the most frequently identified concurrent pathogen [1, 9, 28, 29, 37]. In a study from India, Antiya et al. (2025) reported that 95.77% of diarrheic dogs positive for CPV-2 also harbored CaAstV, and co-infections with canine distemper virus (CDV) and CCoV were also common [29]. The clinical implications of these mixed infections are profound: they are associated with prolonged hospitalization, increased treatment costs, and a significantly higher case fatality rate, particularly in unvaccinated or incompletely vaccinated animals [5, 28]. The molecular mechanisms driving this synergy may include viral interference with host interferon responses, depletion of critical immune cell populations, and direct damage to the intestinal crypt epithelium, which collectively create a permissive environment for the replication of multiple enteric viruses [31].

Extraintestinal Dissemination: A Paradigm Shift in Canine Astrovirus Pathogenesis

Historically considered a strictly enteric pathogen, recent evidence has fundamentally challenged this paradigm by demonstrating that CaAstV can disseminate systemically and establish infection in extraintestinal tissues. Nguyen et al. (2025), using a highly sensitive duplex quantitative PCR assay, detected CaAstV RNA in the spleen, liver, trachea, and mesenteric lymph nodes of naturally infected dogs, providing the first definitive evidence of systemic spread in this species [2]. This finding aligns with observations in other mamastroviruses, where neurotropic strains (e.g., human astrovirus VA1, porcine astrovirus 3, and bovine astrovirus) have been causally linked to encephalitis and neurological disease in immunocompromised hosts [20, 24, 44, 45]. The detection of CaAstV in mesenteric lymph nodes suggests that the virus may traffic from the intestinal mucosa via lymphatic drainage, potentially gaining access to the bloodstream and distant organs. The clinical significance of this extraintestinal dissemination in dogs remains to be fully elucidated, but it raises the possibility that CaAstV may contribute to systemic inflammatory responses, hepatic dysfunction, or even neurological signs in susceptible individuals. Furthermore, the detection of CaAstV in a crab-eating fox (Cerdocyon thous) in Brazil, with evidence of extraintestinal tissue tropism, suggests that systemic infection may be a conserved feature of mamastrovirus 5 across wild and domestic canids [19]. This has important implications for wildlife conservation and the potential for cross-species transmission at the human-animal interface, as dogs and wild canids frequently share habitats and resources [19, 46].

Hemorrhagic Gastroenteritis and High-Mortality Outbreaks

While most CaAstV infections are self-limiting, a distinct and severe clinical phenotype characterized by hemorrhagic gastroenteritis (HGE) and high mortality has been documented in specific outbreak settings, almost invariably in association with co-infections. The most compelling example is the 2021 outbreak in a Hungarian Jack Russell Terrier colony reported by Boros et al. (2022), where a point mutant CPV-2b strain of Asian origin co-infected with CaAstV caused devastating disease in vaccinated puppies [5]. The clinical presentation included acute onset of bloody diarrhea, severe vomiting, rapid dehydration, and death within 24-48 hours in the most severely affected animals. The authors noted that the CPV-2 strain involved was antigenically distinct from the vaccine strains, suggesting that vaccine failure may have contributed to the outbreak severity [5]. This case highlights the potential for CaAstV to act as a disease-modifying agent, tipping the balance from subclinical or mild infection to fatal disease in the presence of other enteric pathogens. The mechanisms underlying this hemorrhagic phenotype likely involve synergistic damage to the intestinal microvasculature, compounded by virus-induced coagulopathy and bacterial translocation. It is noteworthy that similar HGE outbreaks have not been widely reported with CaAstV monoinfection, suggesting that the virus alone is insufficient to induce this severe pathology in immunocompetent dogs. Nevertheless, the high prevalence of CaAstV in canine populations worldwide, coupled with its frequent co-occurrence with CPV-2, CCoV, and canine kobuvirus (CaKoV), means that the potential for such severe outbreaks is ever-present, particularly in environments with high dog density and suboptimal vaccination coverage [1, 5, 27, 43].

Association with Specific Lineages and Genetic Determinants of Virulence

The genetic diversity of CaAstV, particularly within the hypervariable ORF2 capsid gene, has prompted investigations into whether specific viral lineages are associated with distinct clinical phenotypes. Current evidence suggests that all five major CaAstV lineages (1-5) can be detected in both diarrheic and non-diarrheic dogs, indicating that lineage alone is not a reliable predictor of virulence [1, 7, 11, 13]. However, there are intriguing hints that certain strains may possess enhanced pathogenic potential. For instance, the unique lineage identified by Nguyen et al. (2023) in Thailand (strain OR220030_G21) was detected in a diarrheic puppy, and its distinct phylogenetic position suggests it may represent an original lineage with unique biological properties [4]. Similarly, the recombinant strains identified by Loor-Giler et al. (2025) in Ecuador and by Jeong et al. (2026) in South Korea were associated with clinical disease, though the small sample sizes preclude definitive conclusions about their virulence [1, 13]. The capsid protein is the primary target of host neutralizing antibodies, and amino acid substitutions in predicted B-cell epitopes, as documented by Zhang et al. (2020) and Jeong et al. (2026), may facilitate immune evasion and contribute to the persistence of infection in the face of host immunity [7, 13]. Furthermore, the identification of recombination events at the ORF1b-ORF2 junction, which can generate chimeric viruses with novel antigenic and biological properties, underscores the potential for the emergence of more virulent strains [7, 9, 13]. The clinical significance of these genetic changes remains an active area of investigation, and future studies correlating specific capsid mutations with disease severity in controlled experimental infections are urgently needed.

Comparative Clinical Context: Lessons from Other Astroviruses

Understanding the clinical manifestations of CaAstV is enriched by comparison with astrovirus infections in other species. In humans, classic astroviruses (HAstV 1-8) are a leading cause of viral gastroenteritis in children, typically causing mild, self-limiting diarrhea, though severe disease can occur in immunocompromised individuals and the elderly [45, 47]. The emergence of novel human astroviruses (MLB and VA clades) has expanded the disease spectrum to include encephalitis and meningitis, particularly in immunocompromised patients [20, 45]. In poultry, goose astrovirus (GAstV) causes a devastating systemic disease characterized by visceral gout, with mortality rates approaching 50% in goslings, while duck astrovirus causes fatal hepatitis [48-50]. In swine, porcine astrovirus 3 has been linked to polioencephalomyelitis [24]. These examples demonstrate that astroviruses, while typically enteric, have the capacity to cause severe extraintestinal disease under specific host and environmental conditions. The recent evidence for systemic dissemination of CaAstV in dogs [2] suggests that the canine host may be similarly vulnerable to severe systemic disease, particularly in the context of immunosuppression, co-infection, or infection with specific viral strains. This comparative perspective underscores the need for heightened clinical vigilance and the inclusion of CaAstV in the differential diagnosis of canine gastroenteritis, especially in cases that are unusually severe, refractory to treatment, or associated with systemic signs.

Diagnostic Approaches for Canine Astrovirus

The diagnostic armamentarium for canine astrovirus (CaAstV) has undergone a profound transformation over the past two decades, evolving from rudimentary visualization techniques to highly sensitive, multiplexable molecular platforms capable of simultaneous pathogen detection and genomic characterization. This evolution is driven by the recognition of CaAstV as a frequently detected enteric pathogen, often involved in complex co-infection scenarios with viruses such as canine parvovirus type 2 (CPV-2), canine coronavirus (CCoV), canine kobuvirus (CaKoV), and canine distemper virus (CDV) [1, 2, 4, 7, 9]. The high genetic variability of CaAstV, particularly within the ORF2 gene encoding the capsid protein, poses unique challenges for diagnostic assay design, necessitating a strategic focus on conserved genomic regions for robust detection while simultaneously leveraging variable regions for phylogenetic and epidemiological investigations [1, 3, 7, 16]. The following sections delineate the spectrum of diagnostic methodologies, from classical electron microscopy to advanced next-generation sequencing and isothermal amplification, emphasizing their respective utilities, analytical performance characteristics, and practical applications in clinical and research settings.

Historical and Classical Approaches: Electron Microscopy and Virus Isolation

The earliest detection of astrovirus-like particles in canine feces relied heavily on electron microscopy (EM). In a landmark study, Williams (2005) identified 28–30 nm astrovirus-like particles in the diarrheal stools of beagle pups, alongside coronavirus-like and parvovirus-like particles, with the astrovirus particles banding at a density of 1.34 g/mL in cesium chloride gradients [40]. Immunoelectron microscopy (IEM) using convalescent sera further confirmed the aggregation of these particles, providing serological evidence of infection [40]. These classical techniques, while invaluable for the initial discovery and morphological characterization of the virus, suffer from significant limitations, including low throughput, the requirement for highly specialized equipment and trained personnel, and relatively poor sensitivity, particularly when viral shedding is low or when samples are degraded [40, 42]. Virus isolation in cell culture, a gold standard for many virological investigations, has proven notoriously difficult for CaAstV. Unlike some avian astroviruses that have been successfully propagated in cell lines such as LMH or DF-1 [53, 55], or goose astroviruses isolated in embryonated eggs [50, 53, 54], a robust and reliable cell culture system for CaAstV has remained elusive for decades. Reports of CaAstV isolation are exceedingly rare, and the virus is not considered readily cultivable in standard continuous canine cell lines, which has historically hampered detailed pathobiological studies and the development of traditional live-attenuated or inactivated vaccines [42, 44]. This lack of a permissive culture system has rendered molecular detection methods not merely an alternative but the primary and essential means for CaAstV diagnosis and research.

Reverse Transcription Polymerase Chain Reaction (RT-PCR): The Foundation of Molecular Detection

Conventional endpoint RT-PCR targeting the relatively conserved ORF1b gene, which encodes the RNA-dependent RNA polymerase (RdRp), has been the most widely employed molecular technique for initial CaAstV screening and epidemiological surveys [3, 7, 15, 26, 33]. The ORF1b region is favored for its stability and lower genetic drift compared to the hypervariable ORF2 capsid gene [3, 7]. Numerous studies have demonstrated the utility of this approach, with prevalence rates varying considerably depending on the geographic region, health status of the animal population, and primer design. For instance, Zhou et al. (2017) reported a 25.3% positivity rate in diarrheic dogs and 5.9% in non-diarrheic dogs in China using ORF1b-based RT-PCR [15]. Similarly, Zhang et al. (2020) detected CaAstV in 13.2% and 3.35% of diarrheic and non-diarrheic dogs, respectively, using a comparable approach [7]. However, conventional RT-PCR has inherent limitations, including a lack of quantitative capability, the need for post-amplification processing (gel electrophoresis), and a significantly higher limit of detection (LOD) compared to real-time methods. This reduced sensitivity is starkly illustrated by Stamelou et al. (2022), who found that SYBR Green-based real-time RT-PCR detected CaAstV in 15% of dogs (29/201), whereas conventional RT-PCR detected only 7.5% (15/201) from the same sample set [26]. Endpoint RT-PCR is also inherently prone to cross-contamination and does not provide information on viral load, which may be a critical correlate of disease severity or transmissibility.

Quantitative Real-Time RT-PCR (RT-qPCR): Enhancing Sensitivity and Quantification

The advent of real-time quantitative RT-PCR (RT-qPCR) has revolutionized CaAstV diagnostics, offering superior sensitivity, specificity, speed, and the critical ability to quantify viral RNA copy numbers. Two primary chemistries have been employed: intercalating dyes such as SYBR Green and hydrolysis probe-based assays (e.g., TaqMan).

SYBR Green-based assays are cost-effective and straightforward to design, relying on the binding of the fluorescent dye to double-stranded DNA. Loor-Giler et al. (2024) standardized a SYBR Green RT-qPCR targeting the ORF1b gene for CaAstV detection in Ecuador, reporting a remarkably low LOD of one copy of viral genetic material, an efficiency of 103.9%, and excellent reproducibility with inter- and intra-assay coefficients of variation below 10% [3]. Applied to 221 clinical samples, this assay yielded a 53.8% positivity rate, substantially higher than that typically reported using conventional RT-PCR in other regions [3]. Duplex SYBR Green assays have also been developed to discriminate between CaAstV and other co-circulating enteric viruses based on distinct melting temperature (Tm) profiles. Wang et al. (2021) established a duplex assay where CaAstV yields a Tm of approximately 86.5°C, while canine kobuvirus produces a Tm of approximately 80°C, with both targets detectable down to 10 copies/µL [6]. Another duplex assay for CaAstV and canine circovirus demonstrated a Tm of 86°C for CaAstV, with an LOD of 6.15 × 10¹ copies/µL [52]. While highly practical, SYBR Green assays are theoretically less specific than probe-based methods, as any non-specific amplification product or primer-dimer can generate a fluorescent signal. Melting curve analysis is therefore essential for result verification.

TaqMan probe-based assays offer a superior level of specificity through the use of a fluorescently labeled, sequence-specific hydrolysis probe. The probe anneals to the target sequence between the forward and reverse primers and is cleaved during polymerase extension, releasing the fluorophore only when the specific target is present. Loor-Giler et al. (2025) developed and applied a probe-based RT-qPCR for the large-scale surveillance of CaAstV in Ecuador, testing 502 samples and identifying an extraordinarily high positivity rate of 66.9% (336/502) [1]. This assay facilitated the detection of high levels of co-infection with CPV-2 and CCoV, underscoring the utility of sensitive, specific assays for unraveling complex polymicrobial interactions [1]. Nguyen et al. (2025) advanced this approach further by developing a duplex quantitative PCR (dqPCR) using TaqMan probes targeting the conserved ORF1b of Mamastrovirus canis (MAstV5, formerly CaAstV) and the 3D polymerase gene of canine kobuvirus [2]. This assay exhibited remarkable analytical performance, with high linearity (R² > 0.99), an LOD of 10 copies/µL for MAstV5, and no cross-reactivity with CPV, CDV, or CCoV [2]. Intra- and inter-assay coefficients of variation were less than 2.2%, indicating exceptional reproducibility [2]. Most importantly, this assay enabled the detection of CaAstV RNA in extraintestinal tissues, including the spleen, liver, trachea, and mesenteric lymph nodes, providing the first concrete evidence of systemic dissemination of this virus in naturally infected dogs [2]. This finding challenges the long-held dogma that CaAstV is a strictly enteric pathogen and opens new avenues for understanding its pathogenesis. Multiplex TaqMan assays have also been developed for the simultaneous detection of CaAstV alongside CPV, CCoV, and CaKoV, with an LOD of up to 10² copies/µL, providing a powerful tool for comprehensive enteric disease diagnostics [38].

Isothermal Amplification: Point-of-Care and Field-Deployable Diagnostics

The need for rapid, instrument-light diagnostic tests suitable for point-of-care (POC) or field settings has driven the development of isothermal amplification techniques, most notably reverse transcription loop-mediated isothermal amplification (RT-LAMP). Shen et al. (2024) developed and compared two forms of real-time RT-LAMP for CaAstV, both targeting the ORF2 gene: a dye-based method using SYTO-9 and a probe-based method employing a FRET-based assimilating probe [51]. Both assays demonstrated a sensitivity of 100 copies/µL, comparable to many qRT-PCR assays, but with a significantly shorter turnaround time, generating positive fluorescence signals within 30 minutes even at the lowest RNA concentration [51]. When evaluated against a qRT-PCR reference standard using clinical samples, the probe-based RT-LAMP showed superior performance with a positive agreement of 94.11% and a negative agreement of 96.55% [51]. The dye-based assay yielded slightly lower agreements (87.5% positive, 93.55% negative) [51]. The RT-LAMP assays offer distinct advantages for POC applications: they require only a simple heat block or water bath, eliminating the need for expensive thermal cyclers; results can be visualized by the naked eye under UV light or by a color change; and the closed-tube format reduces the risk of amplicon contamination. These features make RT-LAMP an exceptionally promising tool for surveillance in resource-limited settings, emergency outbreak investigations, and routine screening in private veterinary practices.

Next-Generation Sequencing and Viral Metagenomics: Unbiased Detection and Genomic Characterization

Next-generation sequencing (NGS) and viral metagenomics represent the most advanced and comprehensive diagnostic approaches for CaAstV, offering an unbiased, sequence-independent method for pathogen discovery and characterization. Unlike targeted PCR assays, these techniques can detect any virus present in a sample, including novel or highly divergent strains that would escape amplification by specific primers. Bhatta et al. (2019) employed NGS on pooled fecal samples from puppies with gastroenteritis in Australia, successfully obtaining a near-complete CaAstV genome that was 94.7% identical to a UK strain from 2012 [8]. This approach not only identified CaAstV as the likely causative agent but also simultaneously detected the presence of canine papillomavirus and a vaccine strain of canine parvovirus [8]. Boros et al. (2022) used viral metagenomics combined with NGS (VM-NGS) to investigate an outbreak of severe hemorrhagic gastroenteritis in vaccinated purebred Jack Russell Terriers in Hungary [5]. VM-NGS revealed a co-infection with CaAstV and a novel “Asian-origin” CPV-2c-to-2b point mutant, providing critical insights into the etiology of the vaccine-breakthrough outbreak [5]. The complete genomes of both viruses were subsequently determined, enabling detailed phylogenetic and recombination analyses [5]. This unbiased approach is particularly powerful for investigating complex clinical cases where standard diagnostic panels yield negative results, for characterizing the full virome of canine populations, and for detecting cross-species transmission events [12, 14, 41]. Metatranscriptomic analysis of canine fecal samples has uncovered a vast array of viruses, including CaAstV alongside novel viruses from families such as Picornaviridae, Reoviridae, and Caliciviridae [12, 14]. The primary limitations of NGS are its high cost, the need for sophisticated bioinformatics expertise, and a turnaround time that is currently too long for routine clinical decision-making, relegating its use to research, reference laboratories, and outbreak investigations.

Serological Assays: An Underutilized Tool

Despite the availability of molecular methods, serological assays for the detection of antibodies against CaAstV have been described but remain largely underutilized. Immunoelectron microscopy, as demonstrated by Williams (2005), was employed to confirm the presence of astrovirus particles using convalescent sera [40]. However, the development of standardized enzyme-linked immunosorbent assays (ELISAs) for routine serodiagnosis has been hindered by the lack of a reliable cell culture system for antigen production and the significant genetic diversity of the capsid protein, which may result in poor cross-reactivity between lineages. The potential for serological cross-reactivity with astroviruses from other species, given the close genetic relationships observed in phylogenetic analyses [7, 16], also complicates interpretation. Currently, serology is not a mainstay for the clinical diagnosis of active CaAstV infection, but it could play a valuable role in seroprevalence studies to understand population-level exposure and the kinetics of the humoral immune response following natural infection or potential future vaccination.

Recommended Diagnostic Algorithm and Best Practices

Given the available diagnostic arsenal, an evidence-based approach for the detection of CaAstV in clinical and research settings is paramount. For routine diagnostic screening of individual animals with gastroenteritis, a probe-based RT-qPCR targeting the conserved ORF1b gene is currently the recommended first-line assay due to its optimal combination of sensitivity, specificity, quantitative capacity, and speed [1-3]. For epidemiological studies requiring the screening of large sample sets at lower cost, a well-validated SYBR Green RT-qPCR with melting curve analysis is a practical alternative [3, 6]. When co-infection with other major enteric pathogens (CPV-2, CCoV, CaKoV) is suspected or must be ruled out, a validated multiplex TaqMan qPCR panel should be employed to maximize efficiency and diagnostic yield [2, 38]. For field-based surveillance, outbreak investigations in kennels, or situations with limited laboratory infrastructure, the probe-based RT-LAMP assay offers a rapid, sensitive, and instrument-decentralized solution [51]. Finally, for unresolved cases of severe or atypical gastroenteritis, for the identification of novel or recombinant strains, or for comprehensive characterization of the enteric virome, unbiased NGS and metagenomic analysis should be considered, recognizing the associated costs and technical requirements [5, 8, 41].

All molecular diagnostic assays must be rigorously validated with appropriate positive and negative controls, including evaluation against a panel of non-target canine enteric viruses to confirm specificity [1, 3, 51]. Furthermore, the selection of target gene is critical; while ORF1b is optimal for detection, the ORF2 gene is essential for downstream phylogenetic characterization, lineage classification, and recombination analysis [1, 7, 13]. As highlighted by the World Organisation for Animal Health (WOAH) in its guidance for emerging infectious diseases, the integration of molecular diagnostics with genomic surveillance is crucial for tracking viral evolution, monitoring the emergence of new lineages, and informing the development of effective control strategies.

Genetic Diversity and Evolutionary Dynamics

The genetic architecture of canine astrovirus (CaAstV), a member of the species Mamastrovirus 5 (MAstV5) within the genus Mamastrovirus, is characterized by a single-stranded positive-sense RNA genome of approximately 6.6 kb, organized into three open reading frames (ORFs) [1, 3]. ORF1a and ORF1b encode the non-structural proteins, including the RNA-dependent RNA polymerase (RdRp), which is the most conserved region across the Astroviridae family [1, 3, 7]. In contrast, ORF2 encodes the capsid protein, the primary target of the host immune response and the most variable region of the genome [1, 7, 17]. This fundamental dichotomy between a conserved polymerase and a hypervariable capsid gene underpins the remarkable evolutionary plasticity of CaAstV, enabling it to generate substantial genetic diversity while maintaining essential replicative functions. The error-prone nature of the viral RdRp, lacking proofreading capacity, introduces a baseline mutation rate that fuels this variability [7, 21]. However, the most dramatic evolutionary leaps in CaAstV are driven by recombination, a process that can reshuffle entire genomic modules between co-infecting strains, leading to the emergence of novel lineages with distinct antigenic and potentially pathogenic properties [7, 9, 13].

Lineage Classification and Global Phylogenetic Structure

Phylogenetic analyses, primarily based on the highly variable ORF2 (capsid) gene, have consistently resolved circulating CaAstV strains into multiple distinct lineages, reflecting a complex and dynamic global population structure. Early studies proposed classification into four major lineages, with subsequent research expanding this to at least five [1, 7, 15, 39]. A comprehensive analysis of Eurasian and North American strains by Zhang et al. (2020) delineated four lineages (1–4) based on ORF2, revealing that lineage 4 likely originated from a recombination event between ancestral lineage 2 and lineage 3 strains [7]. This finding was corroborated by work in South Korea, where Jeong et al. (2026) identified three co-circulating lineages (1, 2, and 4) in a small sample set, further confirming the global distribution of these major clades [13].

The geographic distribution of these lineages is broad but non-uniform. In Ecuador, a 2025 study employing RT-qPCR and Sanger sequencing of ORF2 from 336 positive samples identified four of the five previously reported lineages, demonstrating the introduction and circulation of multiple genetic variants in South America [1]. Similarly, surveillance in Thailand from 2022–2023 detected CaAstV lineages 1, 3, and 4 in domestic dogs, while a 2023 study in Vietnam and Thailand identified a strain (OR220030_G21/Thailand/2021) that formed a unique, distinct lineage, potentially representing an original ancestral genotype [4, 11]. This pattern of geographically widespread lineages alongside regionally restricted or novel clades suggests ongoing viral dispersal, likely facilitated by the international movement of dogs, combined with localized evolutionary bottlenecks and founder effects.

An alternative nomenclatural system, based on complete ORF2 amino acid sequences, proposed four genotypes within MAstV5: MAstV5a through MAstV5d [18]. This system, while useful for taxonomic clarity, aligns imperfectly with the numbered lineage system. For instance, Brazilian strains classified in genotype ‘a’ showed close relatedness to Chinese samples, whereas other global strains fell into distinct genotypes [18]. The coexistence of multiple classification frameworks highlights the need for a unified, standardized typing scheme for CaAstV, analogous to those used for human astroviruses or noroviruses, to facilitate global epidemiological tracking and evolutionary studies. The dynamic nature of these lineages is further underscored by evidence that the predominant circulating strains within a given lineage can shift over time, driven by amino acid substitutions in predicted B-cell epitopes, suggesting ongoing immune-driven selection [7].

Recombination as a Primary Engine of Diversity

Recombination stands as the most potent force shaping the evolutionary trajectory of CaAstV, capable of generating viruses with dramatically altered genetic backbones and capsid antigenicity in a single event [7, 9, 21]. The first definitive evidence for recombination in CaAstV came from a landmark 2018 study in southwest China, where four of five complete ORF2 sequences cloned from diarrheic dogs exhibited clear recombination signatures, and one strain (2017/44/CHN) had a recombinant genome spanning all three ORFs [9]. This study also identified a continuous 7-amino-acid insertion in the capsid region II of strain 2017/44/CHN, suggesting that recombination can facilitate not only the shuffling of existing genetic material but also the acquisition of novel genetic elements [9].

Subsequent investigations have confirmed that recombination is a recurrent and widespread phenomenon. In China, Zhang et al. (2020) identified frequent inter-clade ORF2 recombinants and, critically, demonstrated that entire lineage 4 itself is a recombinant lineage, providing a powerful example of how recombination can catalyze the emergence of a stable, transmissible clade [7]. Further evidence from South Korea identified a putative recombinant strain, JBN/22D16-1, which possessed a lineage 2-like polymerase backbone (ORF1b) but a lineage 1 capsid (ORF2), with a recombination breakpoint near the ORF1b-ORF2 junction [13]. This precise breakpoint location is suggestive of a modular exchange facilitated by co-infection, where the RdRp and capsid genes can assort independently [13, 21]. The detection of recombinant strains in Ecuador [1] and the high rates of co-infection documented globally, CaAstV is frequently found alongside canine parvovirus, canine coronavirus, and canine kobuvirus [1, 5, 28, 29], create the perfect epidemiological conditions for recombination to occur. The implications are profound: recombination can rapidly alter the antigenic profile of a virus, potentially facilitating immune evasion in vaccinated or previously infected animals, and it may generate viruses with altered host range or tissue tropism [5, 21].

Cross-Species Transmission and Spillover Events

While CaAstV is primarily considered a canine pathogen, accumulating evidence reveals that its evolutionary history is punctuated by cross-species transmission events, challenging the traditional view of strict host specificity among astroviruses [16, 19, 21]. Phylogenetic analyses of the conserved ORF1b gene have revealed a surprisingly close relationship between CaAstV and California sea lion astroviruses, suggesting a historical transmission event between distantly related mammalian hosts [7]. More direct evidence for contemporary inter-species transmission comes from the identification of a canine-like astrovirus (MAstV5) in a free-ranging crab-eating fox (Cerdocyon thous) in Brazil. The nearly complete genome of this strain clustered robustly with CaAstV, indicating likely natural spillover from domestic dogs into wild canid populations and highlighting the potential role of dogs as reservoirs for virus transmission at the human-wildlife interface [19].

This capacity for spillover is further supported by the detection of astrovirus sequences in the fecal virome of high-altitude dogs in China that clustered with known viruses from other species, and the metagenomic identification of CaAstV alongside other novel viruses in dogs [12, 14]. The occurrence of such events is likely facilitated by the high genetic diversity and promiscuous recombination of astroviruses, which can create viruses with novel host-cell interaction capabilities [21]. The detection of a CaAstV recombinant strain with a mink astrovirus-related backbone underscores the potential for transmission across mammalian orders [16]. These findings have significant implications for the World Organisation for Animal Health (WOAH) guidelines on disease surveillance, particularly in regions where domestic dogs and wildlife populations overlap, underscoring the need for a One Health approach that monitors viral flow across species boundaries.

Evolutionary Pressures and Structural Consequences

The evolutionary dynamics of CaAstV are shaped by a balance between purifying (negative) selection, which maintains essential protein functions, and positive (diversifying) selection, which drives antigenic variation. Selective pressure analyses on the ORF2 capsid gene have consistently demonstrated that the majority of codons evolve under strong negative selection, preserving the structural integrity of the capsid core and spike domains [4, 10, 13]. However, discrete sites within the capsid, particularly in the surface-exposed spike domain, are subject to positive selection [4, 10]. These positively selected sites often map to predicted B-cell epitopes, providing direct evidence that host adaptive immunity is a primary driver of CaAstV evolution [7, 13].

The structural consequences of this evolutionary pressure have been elegantly elucidated for South Korean strains. Homology modeling and Alphafold prediction of the capsid spike domain revealed a conserved core β-barrel topology, with most amino acid variation concentrated in surface-exposed loops and peripheral β-strands [13]. Shannon entropy analysis identified discrete hypervariable regions within this otherwise conserved scaffold. Critically, these variable segments were found to contain the majority of predicted linear B-cell epitopes, confirming that the virus is engaging in an evolutionary arms race with the host immune system, targeting the most accessible and immunogenic regions of its capsid [13]. This pattern mirrors that observed in human astroviruses, where the capsid spike is the target of neutralizing antibodies and exhibits serotype-specific variability [22, 23]. The identification of lineage-specific epitope patterns, such as a conserved GQKSNSQY motif in lineage 4 strains and a conserved C-terminal epitope in lineage 1, suggests that antigenic diversity is structured along phylogenetic lines, which may have practical implications for the future development of broadly protective vaccines or diagnostic assays [13]. The absence of recombination events detected in some studies [4, 10] compared to their high frequency in others [7, 9] may reflect differences in the circulating viral populations, the temporal and geographic scale of sampling, or the methodologies used for detection. Nevertheless, the cumulative evidence paints a picture of a rapidly diversifying virus, whose genetic and antigenic heterogeneity poses a significant challenge for diagnostics and control strategies [7, 11].

Co-infection Dynamics and Synergistic Pathogenesis

The clinical significance of canine astrovirus (CaAstV) must be evaluated within the complex ecological framework of the canine enteric virome, where co-infection is not the exception but the prevailing rule. A growing body of epidemiological and molecular evidence, drawn from geographically disparate canine populations across five continents, unequivocally demonstrates that CaAstV rarely acts as a solitary pathogen. Instead, it operates within a dynamic consortium of enteric viruses, where its presence is frequently associated with heightened disease severity, therapeutic failure, and unexpected mortality. Understanding these co-infection dynamics is therefore not merely an academic exercise; it is a prerequisite for accurate diagnosis, rational therapeutic intervention, and the development of effective prophylactic strategies. This section dissects the intricate web of interactions between CaAstV and its most common viral partners, exploring the epidemiological patterns, clinical consequences, and the putative biological mechanisms that underpin synergistic pathogenesis.

Epidemiological Landscape of Co-infection

The frequency with which CaAstV is detected alongside other enteric pathogens is striking and consistent across diverse ecological and climatic settings. In a comprehensive molecular survey conducted in Ecuador, Loor-Giler et al. (2025) reported that among 336 CaAstV-positive dogs, a staggering 49.4% were co-infected with canine parvovirus type 2 (CPV-2), while 4% harbored a triple infection involving CPV-2 and canine coronavirus (CCoV) [1]. This pattern is not unique to South America. In southwest China, Li et al. (2018) found that 41 of 42 CaAstV-positive diarrheic samples (97.6%) were co-infected with at least one other virus, including CCoV, CPV-2, and canine distemper virus (CDV) [9]. Similarly, in a study spanning Vietnam and Thailand, Nguyen et al. (2023) documented frequent co-detection of CaAstV with CPV-2, CCoV, CDV, and canine kobuvirus (CaKoV), with the highest prevalence observed in puppies under six months of age [4]. These data suggest a near-ubiquitous pattern: CaAstV is a component of a polymicrobial enteric infection in a substantial proportion of clinical cases.

The prevalence of specific co-infection combinations varies regionally, likely reflecting the local circulation dynamics of individual pathogens and management practices. In Greece, Stamelou et al. (2025) employed advanced statistical methods, including Multiple Correspondence Analysis and Ascending Hierarchical Classification, to demonstrate that CaAstV infection clusters within a specific demographic: low-health-status mongrel dogs living in rural environments with frequent contact with stray animals [25]. This group exhibited a constellation of clinical signs including vomiting, diarrhea, and diet changes, suggesting that environmental and host factors synergize with viral co-infections to produce overt disease. In Shanghai, China, Deng et al. (2023) reported that 73.33% of CaKoV-positive stray dogs were co-infected with CaAstV, highlighting a particularly strong association between these two emerging enteric viruses [27]. The development of advanced molecular tools, such as the duplex SYBR Green I-based real-time PCR assays for simultaneous detection of CaAstV with CaKoV [6] or canine circovirus (CaCV) [52], has facilitated the identification of these mixed infections with unprecedented sensitivity, revealing co-infection rates that were previously underestimated by conventional methods.

Synergistic Pathogenesis with Canine Parvovirus Type 2 (CPV-2)

The most clinically consequential partnership for CaAstV appears to be with CPV-2, a highly virulent, non-enveloped DNA virus that is a leading cause of hemorrhagic gastroenteritis and myocarditis in dogs worldwide. The frequency of this specific co-infection is remarkable. In the Ecuadorian study, CPV-2 was the dominant co-infecting agent, present in nearly half of all CaAstV-positive cases [1]. In India, Antiya et al. (2025) found that CPV-2 was the most prevalent virus overall (73.8%), and co-infections involving CPV-2 and CDV were the most common combination, with CaAstV also frequently participating [29]. Zobba et al. (2021) in Italy reported that CPV-2 was present in 100% of co-infected animals, underscoring its role as a central node in the canine enteric co-infection network [37].

The most compelling evidence for synergistic pathogenesis comes from a detailed outbreak investigation in Hungary. Boros et al. (2022) described an epizootic of severe hemorrhagic gastroenteritis (HGE) with high mortality in a colony of purebred Jack Russell Terriers that had been vaccinated against CPV-2 [5]. Viral metagenomics and next-generation sequencing revealed a dual infection with an unusual “Asian-origin” CPV-2c-to-2b point mutant strain and a CaAstV strain. The CPV-2 strain was genetically distinct from the vaccine strains, suggesting a vaccine breakthrough. Critically, the authors posited that the CaAstV co-infection may have played a pivotal role in the development and severity of the HGE, as CPV-2 alone, even in unvaccinated animals, does not invariably produce such a fulminant, fatal outcome. This case study provides a stark illustration of how co-infection can overcome vaccine-induced immunity and precipitate disease of exceptional severity.

The biological mechanisms underpinning this synergy are likely multifaceted. CPV-2 is known to cause profound immunosuppression through the depletion of lymphoid cells and the destruction of intestinal crypt epithelium, leading to a compromised mucosal barrier and secondary bacterial translocation. It is plausible that CaAstV, which infects intestinal epithelial cells and, as demonstrated in murine models, actively secreting goblet cells [31], exploits this immunocompromised state. The astrovirus-induced disruption of the mucus barrier, as described by Cortez et al. (2020), could further exacerbate the loss of epithelial integrity caused by CPV-2, creating a “leaky gut” that facilitates systemic dissemination of both viruses and secondary bacterial invaders [31]. Furthermore, the high viral loads of CaAstV observed in young dogs [3] may directly contribute to the severity of parvoviral enteritis by overwhelming the regenerative capacity of the intestinal epithelium.

Co-infection with Other Enteric Viruses: Expanding the Pathogenic Consortium

Beyond CPV-2, CaAstV frequently co-occurs with a diverse array of other enteric viruses, each potentially contributing to the overall disease phenotype. The interaction with CCoV is well-documented. He et al. (2020) in China found that co-infection with CPV, CaAstV, CaKoV, and Torque teno canis virus (TTCaV) was ubiquitous among CCoV-positive diarrheic dogs [36]. The presence of multiple coronaviruses and astroviruses simultaneously may lead to competitive or cooperative interactions at the cellular level, though the precise dynamics remain poorly understood.

The association between CaAstV and CaKoV is particularly intriguing, given that both are relatively recently recognized pathogens. Nguyen et al. (2025) developed a duplex qPCR assay specifically for these two agents and demonstrated their co-occurrence in clinical samples, with viral RNA detected not only in feces but also in extraintestinal tissues including spleen, liver, trachea, and mesenteric lymph nodes [2]. This finding of systemic dissemination in naturally infected dogs suggests that co-infection may facilitate viral spread beyond the gastrointestinal tract, potentially leading to more severe systemic disease. In Ecuador, Sanchez-Castro et al. (2025) reported that 61.3% of CaKoV-positive samples were co-infected with other enteric viruses, with triple co-infections (CPV-2, CaAstV, and CaKoV) being the most frequent combination [43]. This triad of pathogens may represent a particularly pathogenic consortium.

Co-infection with CDV, a morbillivirus that causes a multisystemic disease with high mortality, has also been documented. Dema et al. (2022) in India identified CDV as the second most common virus after CPV-2, and it was frequently found in mixed infections with CaAstV [28]. The immunosuppressive effects of CDV, which targets lymphoid tissue and causes profound lymphopenia, could similarly predispose dogs to secondary CaAstV infection or reactivation. The detection of CaAstV in association with canine bocavirus (CBoV) [41], canine circovirus (CaCV) [52], and the novel chaphamaparvovirus, cachavirus [56], further expands the spectrum of potential viral interactions. The identification of CaAstV co-infection with TTCaV [7] and with multiple bacterial pathogens in research Beagle colonies [57] underscores the polymicrobial nature of canine gastroenteritis and the need for comprehensive diagnostic panels.

Mechanistic Basis for Synergistic Pathogenesis

The molecular and cellular mechanisms driving the observed clinical synergy remain an active area of investigation, but several plausible hypotheses can be advanced based on the known biology of astroviruses and their co-infecting partners. First, the disruption of the intestinal epithelial barrier is a common theme. CPV-2, CDV, and CCoV all cause varying degrees of enterocyte destruction and villus atrophy. CaAstV, by infecting goblet cells and altering mucus production [31], may compromise the protective mucus layer, making the underlying epithelium more susceptible to damage by other viruses and facilitating bacterial translocation. This could explain the increased severity of hemorrhagic gastroenteritis observed in co-infected animals.

Second, viral-induced immunosuppression is a critical factor. CPV-2 and CDV are both known to cause lymphoid depletion and impair both humoral and cell-mediated immune responses. In this immunocompromised environment, CaAstV may replicate to higher titers and for a longer duration, exacerbating intestinal damage. Conversely, astrovirus infection itself may modulate the host immune response in ways that favor the replication of other viruses. The ability of astrovirus capsid proteins to bind complement components and inhibit complement activation [23] could represent a mechanism for evading innate immune defenses, potentially creating a permissive environment for co-infecting pathogens.

Third, the phenomenon of viral recombination, which is a hallmark of astrovirus evolution, may be facilitated by co-infection. The high genetic variability of CaAstV is driven in part by an error-prone RNA-dependent RNA polymerase and frequent recombination events [21]. Co-infection of a single cell with two different CaAstV strains, or even with a CaAstV and another enteric virus, could provide the substrate for recombination, generating novel chimeric viruses with altered tropism, virulence, or antigenicity. Indeed, multiple studies have identified recombinant CaAstV strains [1, 7, 9, 13], and the presence of a unique lineage in Thailand [4] and the identification of putative inter-lineage recombinants in Ecuador [1] and South Korea [13] suggest that co-infection is a driving force for genetic diversification. This has profound implications for vaccine design and diagnostic assay development, as recombinant viruses may escape detection or immunity.

Finally, the potential for extraintestinal spread, as demonstrated by the detection of CaAstV RNA in systemic tissues [2], may be enhanced in the context of co-infection. The breakdown of the intestinal barrier caused by CPV-2 or CDV could provide a portal of entry for CaAstV into the bloodstream, allowing it to reach organs such as the liver, spleen, and mesenteric lymph nodes. Once there, CaAstV may contribute to systemic inflammation and multi-organ dysfunction, compounding the pathology caused by the primary pathogen. This concept of “pathogen-assisted translocation” represents a novel and clinically important dimension of CaAstV pathogenesis.

In summary, CaAstV is not an innocent bystander in the canine enteric virome. It is an active participant in a complex network of viral interactions that can dramatically alter the course of disease. The high frequency of co-infection, particularly with CPV-2, and the documented association with severe, often fatal, gastroenteritis in vaccinated animals, underscore the urgent need to incorporate CaAstV into routine diagnostic algorithms. The mechanisms of synergy, barrier disruption, immunosuppression, recombination, and systemic dissemination, are likely interconnected and amplify the pathogenic potential of each individual virus. Future research must focus on elucidating these mechanisms at the molecular level, using both in vitro co-infection models and in vivo studies in gnotobiotic dogs, to inform the development of targeted interventions, including multivalent vaccines that can mitigate the devastating consequences of polymicrobial enteric disease.

References

[1] Loor-Giler A, Santander-Parra S, Castillo-Reyes S, Campos M, Mena-Pérez R, Prado-Chiriboga S, et al.. Molecular characterization and lineage analysis of canine astrovirus strains from dogs with gastrointestinal disease in Ecuador based on ORF-2 gene analysis. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2024.1505903

[2] Nguyen TV, Kasantikul T, Piewbang C, Techangamsuwan S. Simultaneous detection of canine astrovirus and canine kobuvirus by duplex qPCR: validation and evidence of extraintestinal viral RNA in naturally infected dogs. Journal of Veterinary Diagnostic Investigation. 2025. DOI: https://doi.org/10.1177/10406387251382915

[3] Loor-Giler A, Castillo-Reyes S, Santander-Parra S, Campos M, Mena-Pérez R, Prado-Chiriboga S, et al.. First Report on the Molecular Detection of Canine Astrovirus (CaAstV) in Dogs with Gastrointestinal Disease in Ecuador Using a Fast and Sensitive RT-qPCR Assay Based on SYBR Green®. Veterinary Sciences. 2024. DOI: https://doi.org/10.3390/vetsci11070303

[4] Nguyen TV, Piewbang C, Techangamsuwan S. Genetic characterization of canine astrovirus in non-diarrhea dogs and diarrhea dogs in Vietnam and Thailand reveals the presence of a unique lineage. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1278417

[5] Boros Á, Albert M, Urbán P, Herczeg R, Gáspár G, Balázs B, et al.. Unusual “Asian-origin” 2c to 2b point mutant canine parvovirus (Parvoviridae) and canine astrovirus (Astroviridae) co-infection detected in vaccinated dogs with an outbreak of severe haemorrhagic gastroenteritis with high mortality rate in Hungary. Veterinary research communications. 2022. DOI: https://doi.org/10.1007/s11259-022-09997-2

[6] Wang Y, Li Y, Cui Y, Jiang S, Liu H, Wang J, et al.. Duplex SYBR Green I-based real-time PCR assay for the rapid detection of canine kobuvirus and canine astrovirus.. Journal of Virological Methods. 2021. DOI: https://doi.org/10.1016/j.jviromet.2021.114066

[7] Zhang W, Wang R, Liang J, Zhao N, Li G, Gao Q, et al.. Epidemiology, genetic diversity and evolution of canine astrovirus.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13663

[8] Bhatta T, Chamings A, Vibin J, Alexandersen S. Detection and characterisation of canine astrovirus, canine parvovirus and canine papillomavirus in puppies using next generation sequencing. Scientific Reports. 2019. DOI: https://doi.org/10.1038/s41598-019-41045-z

[9] Li M, Yan N, Ji C, Wang M, Zhang B, Yue H, et al.. Prevalence and genome characteristics of canine astrovirus in southwest China.. Journal of General Virology. 2018. DOI: https://doi.org/10.1099/jgv.0.001077

[10] Nguyen TV. Molecular investigation and genetic characterization of canine astrovirus and canine kobuvirus with associated pathology in domestic dogs in Vietnam and Thailand. . None. DOI: https://doi.org/10.58837/chula.the.2023.1455

[11] Thaw YN, Charoenkul K, Nasamran C, Chamsai E, Jairak W, Phyu EM, et al.. Monitoring and characterization of canine and feline astroviruses in domestic dogs and cats in Thailand. Scientific Reports. 2025. DOI: https://doi.org/10.1038/s41598-025-03037-0

[12] Gao W, Yao Y, Sun Y, Pu W, Xu L. Metatranscriptomic characterization of the canine fecal virome from pooled samples in Gansu, China. Virus Research. 2025. DOI: https://doi.org/10.1016/j.virusres.2025.199666

[13] Jeong C, Chae S, Jeoung H, Lee K, Oem J. Genetic characterization and structural insights of canine astroviruses circulating in South Korea. BMC Veterinary Research. 2026. DOI: https://doi.org/10.1186/s12917-026-05370-6

[14] Jiang X, Liu J, Xi Y, Zhang Q, Wang Y, Zhao M, et al.. Virome of high-altitude canine digestive tract and genetic characterization of novel viruses potentially threatening human health. Msphere. 2023. DOI: https://doi.org/10.1128/msphere.00345-23

[15] Zhou H, Liu L, Li R, Qin Y, Fang Q, Balasubramaniam V, et al.. Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China. Virology Journal. 2017. DOI: https://doi.org/10.1186/s12985-017-0823-4

[16] Mihalov-Kovács E, Martella V, Lanave G, Bodnar L, Fehér E, Marton S, et al.. Genome analysis of canine astroviruses reveals genetic heterogeneity and suggests possible inter-species transmission. Virus Research. 2016. DOI: https://doi.org/10.1016/j.virusres.2016.12.005

[17] Toffan A, Jonassen C, Battisti CD, Schiavon E, Kofstad T, Capua I, et al.. Genetic characterization of a new astrovirus detected in dogs suffering from diarrhoea. Veterinary Microbiology. 2009. DOI: https://doi.org/10.1016/j.vetmic.2009.04.031

[18] Alves CD, Budaszewski RF, Torikachvili M, Streck AF, Weber MN, Cibulski S, et al.. Detection and genetic characterization of Mamastrovirus 5 from Brazilian dogs. Brazilian Journal of Microbiology. 2018. DOI: https://doi.org/10.1016/j.bjm.2017.09.008

[19] Alves CDBT, Budaszewski RdF, Cibulski S, Weber MN, Mayer FQ, Bianchi MV, et al.. Mamastrovirus 5 detected in a crab-eating fox (Cerdocyon thous): Expanding wildlife host range of astroviruses. Comparative Immunology, Microbiology & Infectious Diseases. 2018. DOI: https://doi.org/10.1016/j.cimid.2018.08.002

[20] Aguilera-Flores C, López T, Zamudio F, Sandoval-Jaime C, Pérez EI, López S, et al.. The Capsid Precursor Protein of Astrovirus VA1 Is Proteolytically Processed Intracellularly. bioRxiv. 2022. DOI: https://doi.org/10.1128/jvi.00665-22

[21] Wohlgemuth N, Honce R, Schultz‐Cherry S. Astrovirus evolution and emergence. Infection, Genetics and Evolution. 2019. DOI: https://doi.org/10.1016/j.meegid.2019.01.009

[22] Ricemeyer L, Aguilar-Hernández N, López T, Espinosa R, Lanning S, Mukherjee S, et al.. Structures of Two Human Astrovirus Capsid/Neutralizing Antibody Complexes Reveal Distinct Epitopes and Inhibition of Virus Attachment to Cells. Journal of Virology. 2021. DOI: https://doi.org/10.1128/JVI.01415-21

[23] Arias C, DuBois R. The Astrovirus Capsid: A Review. Viruses. 2017. DOI: https://doi.org/10.3390/v9010015

[24] Ferreyra FSM, Bradner L, Burrough ER, Cooper V, Derscheid R, Gauger P, et al.. Polioencephalomyelitis in Domestic Swine Associated With Porcine Astrovirus Type 3. Veterinary Pathology-Supplement. 2020. DOI: https://doi.org/10.1177/0300985819875741

[25] Stamelou E, Papageorgiou K, Papadopoulos D, Delis G, Chatzopoulos DC, Athanasakopoulou Z, et al.. Towards Detecting Associations of Canine Astrovirus and Caliciviruses with Health and Living Characteristics of Dogs in Greece. Pathogens. 2025. DOI: https://doi.org/10.3390/pathogens14010092

[26] Stamelou E, Giantsis IA, Papageorgiou K, Petridou E, Davidson I, Polizopοulou ZS, et al.. First report of canine Astrovirus and Sapovirus in Greece, hosting both asymptomatic and gastroenteritis symptomatic dogs. Virology Journal. 2022. DOI: https://doi.org/10.1186/s12985-022-01787-1

[27] Deng B, Song Y, Li L, Zhou Y, Zhu C, Zhang W, et al.. Detection and genetic characterization of canine kobuvirus from stray dogs in Shanghai, China. Archives of Virology. 2023. DOI: https://doi.org/10.1007/s00705-023-05710-z

[28] Dema A, Tallapally M, Ganji V, Buddala B, Kodi H, Ramidi A, et al.. A comprehensive molecular survey of viral pathogens associated with canine gastroenteritis. Archives of Virology. 2022. DOI: https://doi.org/10.1007/s00705-022-05674-6

[29] Antiya SP, Patel AC, Sharma KK, Chauhan HC, Patel SS, Mohapatra SK, et al.. Molecular detection of enteric viruses in symptomatic and asymptomatic dogs in Gujarat, India.. Comparative Immunology, Microbiology & Infectious Diseases. 2025. DOI: https://doi.org/10.1016/j.cimid.2025.102356

[30] Delgado-Cunningham K, López T, Khatib F, Arias C, DuBois R. Structure of the Divergent Human Astrovirus MLB Capsid Spike. Structure. 2022. DOI: https://doi.org/10.1016/j.str.2022.10.010

[31] Cortez V, Boyd DF, Crawford J, Sharp B, Livingston B, Rowe HM, et al.. Astrovirus infects actively secreting goblet cells and alters the gut mucus barrier. Nature Communications. 2020. DOI: https://doi.org/10.1038/s41467-020-15999-y

[32] Caddy S, Goodfellow I. Complete genome sequence of canine astrovirus with molecular and epidemiological characterisation of UK strains. Veterinary Microbiology. 2015. DOI: https://doi.org/10.1016/j.vetmic.2015.03.011

[33] Takano T, Takashina M, Doki T, Hohdatsu T. Detection of canine astrovirus in dogs with diarrhea in Japan. Archives of Virology. 2015. DOI: https://doi.org/10.1007/s00705-015-2405-3

[34] Sawant P, Waghchaure R, Shinde P, Palikondawar AP, Lavania M. Detection and Molecular Characterization of Animal Adenovirus and Astrovirus from Western Maharashtra, India. bioRxiv. 2023. DOI: https://doi.org/10.1101/2023.05.01.539015

[35] Deus DRD, Siqueira JAM, Teixeira DM, Maués MAC, Figueiredo MJdFMd, Sousa EC, et al.. Nearly Complete Genome Sequences of Two Canine Mamastrovirus 5 Strains from Latin America. Microbiology Resource Announcements. 2023. DOI: https://doi.org/10.1128/mra.01315-22

[36] He H, Zhang W, Liang J, Lu M, Wang R, Li G, et al.. Etiology and genetic evolution of canine coronavirus circulating in five provinces of China, during 2018–2019. Microbial Pathogenesis. 2020. DOI: https://doi.org/10.1016/j.micpath.2020.104209

[37] Zobba R, Visco S, Sotgiu F, Parpaglia MLP, Pittau M, Alberti A. Molecular survey of parvovirus, astrovirus, coronavirus, and calicivirus in symptomatic dogs. Veterinary research communications. 2021. DOI: https://doi.org/10.1007/s11259-020-09785-w

[38] Wang R, Zhang W, Ye R, Pan Z, Li G, Su S. One-step multiplex TaqMan probe-based method for real-time PCR detection of four canine diarrhea viruses. Molecular and Cellular Probes. 2020. DOI: https://doi.org/10.1016/j.mcp.2020.101618

[39] Choi S, Lim S, Kim YK, Cho Y, Song J, An D. Phylogenetic Analysis of Astrovirus and Kobuvirus in Korean Dogs. Journal of Veterinary Medical Science. 2014. DOI: https://doi.org/10.1292/jvms.13-0585

[40] Williams F. Astrovirus-like, coronavirus-like, and parvovirus-like particles detected in the diarrheal stools of beagle pups. Archives of Virology. 2005. DOI: https://doi.org/10.1007/BF01314735

[41] Sobhy N, Armién A, Pilot J, Singh V, Padhi S, Muldoon D, et al.. Detection and molecular characterization of astro and bocaviruses in dogs in Minnesota.. Comparative Immunology, Microbiology & Infectious Diseases. 2021. DOI: https://doi.org/10.1016/j.cimid.2021.101740

[42] Filho AFdS, Bernabé M, Coelho EC, Binda RM, Oliveira SFCd, Moscon LA, et al.. Astrovirose canina: Revisão. . 2020. DOI: https://doi.org/10.31533/pubvet.v14n8a635.1-4

[43] Sanchez-Castro C, Loor-Giler A, Santander-Parra S, Campos M, Mena-Pérez R, Prado-Chiriboga S, et al.. First Molecular Insights into the Presence of Canine Kobuvirus in Ecuadorian Dogs Through the Standardization of a Sensitive SYBR Green RT-qPCR Assay. Veterinary Sciences. 2025. DOI: https://doi.org/10.3390/vetsci12111076

[44] Zhu Q, Li B, Sun D. Bovine Astrovirus, A Comprehensive Review. Viruses. 2022. DOI: https://doi.org/10.3390/v14061217

[45] Vu D, Bosch A, Pintó R, Guix S. Epidemiology of Classic and Novel Human Astrovirus: Gastroenteritis and Beyond. Viruses. 2017. DOI: https://doi.org/10.3390/v9020033

[46] Payne N, Andersen D, Mollohan C, Doorslaer Kv, Combrink L, Culver M. Urbanisation and Host Relatedness Shape Virome Composition in a Widespread, Generalist Carnivore. Molecular Ecology. 2025. DOI: https://doi.org/10.1111/mec.17681

[47] Farahmand M, Khales P, Salavatiha Z, Sabaei M, Hamidzade M, Aminpanah D, et al.. Worldwide prevalence and genotype distribution of human astrovirus in gastroenteritis patients: A systematic review and meta-analysis.. Microbial Pathogenesis. 2023. DOI: https://doi.org/10.1016/j.micpath.2023.106209

[48] Liu C, Sun M, Liao M. A Review of Emerging Goose Astrovirus Causing Gout. BioMed Research International. 2022. DOI: https://doi.org/10.1155/2022/1635373

[49] Zhu Q, Sun D. Goose Astrovirus in China: A Comprehensive Review. Viruses. 2022. DOI: https://doi.org/10.3390/v14081759

[50] Zhang Q, Cao Y, Wang J, Fu G, Sun M, Zhang L, et al.. Isolation and characterization of an astrovirus causing fatal visceral gout in domestic goslings. Emerging Microbes and Infections. 2018. DOI: https://doi.org/10.1038/s41426-018-0074-5

[51] Shen H, Yang D, Li X, Ju H, Ge F, Yang X, et al.. Comparison of dye-based and probe-based RT-LAMP in detection of canine astrovirus. Archives of Virology. 2024. DOI: https://doi.org/10.1007/s00705-023-05913-4

[52] Wang Y, Li Y, Cui Y, Jiang S, Liu G, Wang J, et al.. Establishment of a duplex SYBR green I-based real-time polymerase chain reaction assay for the rapid detection of canine circovirus and canine astrovirus. Molecular and Cellular Probes. 2020. DOI: https://doi.org/10.1016/j.mcp.2020.101666

[53] Zhu Q, Miao Y, Wang J, Bai W, Yang X, Yu S, et al.. Isolation, identification, and pathogenicity of a goose astrovirus causing fatal gout in goslings.. Veterinary Microbiology. 2022. DOI: https://doi.org/10.1016/j.vetmic.2022.109570

[54] Wang A, Zhang S, Xie J, Gu L, Wu S, Wu Z, et al.. Isolation and characterization of a goose astrovirus 1 strain causing fatal gout in goslings, China. Poultry Science. 2021. DOI: https://doi.org/10.1016/j.psj.2021.101432

[55] Li J, Hu W, Liu T, Zhang H, Opriessnig T, Xiao C. Isolation and evolutionary analyses of gout-associated goose astrovirus causing disease in experimentally infected chickens. Poultry Science. 2020. DOI: https://doi.org/10.1016/j.psj.2020.11.003

[56] Li N, Bai Y, Yan X, Guo Z, Xiang K, Yang Z, et al.. The prevalence, genetic diversity and evolutionary analysis of cachavirus firstly detected in northeastern China. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1233972

[57] Zhao Y, Wang P, Qu X, Yuan K, Zhu S, Wang S, et al.. Investigation of circulating infectious agents in experimental Beagle dogs of a production colony and three research facilities in China from June 2021 to May 2022. Laboratory Animals. Journal of the Laboratory Animal Science Association. 2023. DOI: https://doi.org/10.1177/00236772231188172